Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
268 studies found for:    603
Show Display Options
Rank Status Study
1 Completed LFB-R603 Dose Finding in Patients With Advanced Stage B-Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: LFB-R603
2 Not yet recruiting Study of Molecular-targeted Therapy Using Zinc Finger Nuclease in Cervical Precancerous Lesions
Condition: Human Papillomavirus-Related Malignant Neoplasm
Intervention: Biological: ZFN-603 and ZFN-758
3 Not yet recruiting CCTG 603: Randomized Controlled Trial of iTAB Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals (The iM-PrEPT Study)
Conditions: Patient Adherence;   HIV Seronegativity
Intervention: Behavioral: brief Motivational Interviewing
4 Completed Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)
Condition: Dry Eye Syndromes
Intervention: Drug: cyclosporine A
5 Completed Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)
Condition: Dry Eye Syndromes
Intervention: Drug: cyclosporine
6 Completed Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)
Condition: Dry Eye Syndromes
Intervention: Drug: cyclosporine
7 Active, not recruiting Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses
Conditions: Neuromyelitis Optica;   Neuromyelitis Optica Spectrum Disorder
Intervention: Drug: Ublituximab
8 Active, not recruiting Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: adult human mesenchymal stem cells
9 Active, not recruiting Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: adult human mesenchymal stem cells;   Drug: Placebo
10 Completed
Has Results
Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®
Conditions: Meningitis;   Meningococcal Infection
Intervention: Biological: Polysaccharide Diphtheria Conjugate Vaccine
11 Completed Study of Sivelestat Sodium Hydrate in Acute Lung Injury (ALI) Associated With Systemic Inflammatory Response Syndrome (SIRS) in Japan
Conditions: Acute Lung Injury;   Systemic Inflammatory Response Syndrome
Intervention: Drug: Sivelestat sodium hydrate
12 Completed Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: Placebo;   Drug: PROCHYMAL adult human mesenchymal stem cells
13 Completed
Has Results
Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis
Condition: Bacterial Conjunctivitis
Interventions: Drug: Besifloxacin;   Drug: Vehicle (Placebo)
14 Terminated Evaluation of Cardiac Compass With OptiVol in the Early Detection of Decompensation Events for Heart Failure
Condition: Congestive Heart Failure
Intervention: Device: Cardiac Compass with OptiVol Fluid Status Monitoring
15 Recruiting Reliability of Fluorescent Camera and Caries Detection Dye Versus the Visual Tactile Method
Condition: Dental Caries
Interventions: Device: fluorescent camera;   Other: caries detector dye;   Diagnostic Test: visual tactile assessment
16 Completed Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acute Spinal Cord Injury (ASCI)
Condition: Acute Spinal Cord Injury
Interventions: Drug: SUN13837 injection;   Drug: Placebo
17 Completed Washington State Community Expedited Partner Treatment (EPT) Trial
Conditions: Gonorrhea;   Neisseria Gonorrhoeae;   Chlamydia Trachomatis
Interventions: Other: Patient delivered partner therapy;   Behavioral: Targeted public health partner services
18 Completed
Has Results
Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART)
Conditions: Controlled Ovarian Stimulation;   Infertility
Interventions: Drug: recombinant luteinizing hormone (r-LH);   Drug: recombinant human chorionic gonadotropin (r-hCG)
19 Completed Anesthetics and Auditory, Visceral, and Heat Evoked Potentials
Condition: Healthy
Interventions: Drug: Propofol;   Drug: Remifentanil;   Drug: S-Ketamine;   Drug: Sevoflurane
20 Active, not recruiting Von Hippel-Lindau Disease Genetic Epidemiology Study
Conditions: Von Hippel Lindau Disease;   Kidney Neoplasms
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.